3 completed, 1 unknown. 2 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow psilocin: new trials by email Literature Review of psilocin trials Research Report on psilocin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers Psilocybin, Cognitive Behavioral Therapy (CBT) - Major Depressive Disorder | Phase 2 | Completed | Khyber Medical University Peshawar | 60 | 2024-12-01 | 2025-09-02 |
| Evaluation of Safety, Rate and Extent of Absorption of Psilocin Mucate Psilocin - Side Effect of Drug | Phase 1 | Completed | Lobe Sciences Ltd. | 10 | 2023-06-21 | 2023-09-13 |
| Comparing the Effects of Psilocin and Psilocybin in Healthy Adults Psilocin, Psilocybin, Sublingual Psilocin - Healthy | Phase 1 | Unknown | University of California, San Francisco | 20 | 2022-05-26 | 2025-06-10 |
| Precision Functional Brain Mapping in Psilocybin Psilocybin, Methylphenidate - Psilocybin | Early Phase 1 | Completed | Washington University School of Medicine | 11 | 2021-06-01 | 2025-10-31 |
Depressive Disorder, Major (1)
Khyber Medical University Peshawar (1) · Lobe Sciences Ltd. (1) · University of California, San Francisco (1) · Washington University School of Medicine (1)
United States (2) · Jordan (1) · Pakistan (1)
Ahmad Abdulkhaleq, MD (1) · Dr Mahvash Khan (1) · Joshua Woolley, MD/PhD (1)